Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

September 19, 2007

Soma re-visited??

Analysis of: FDA approves SOMA 250 mg | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
David Zimmerman, PharmD
President/Owner, Doctors of Pharmacy, Inc.
Implications: Soma has been around for many years. Now we have a new strength? Probably because there is no generic available on the 250mg.

Analysis: We have used Soma  350mg and its generic for 20 plus years. The junkies started using this drug because of the abuse factor.
In the old days the drug was made by Wallace, now it was sold to Medpointe...and revived with a new strength. Clever marketing!
The current acquisition cost to a pharmacy of generic Soma 350mg is 0.03/tablet (3 cents). The current acquisition cost to a pharmacy of the new Soma 250mg is $2.25/tablet. Quite a difference in price!
Why would a physician prescribe it due to the price differential?
Why would a cash patient pay for it due to the price differential?
Why would a PBM put Soma 250mg on its formulary?
Good Luck.

Other Analyses of the Same Source Article:
New Dose For Old Drug
October 1, 2007, Author: Tim Gallagher, RPh, Executive Vice President of Pharmacy Operations , Astrup Drug, Inc.
Lower safer dose of Soma approved by FDA
September 24, 2007, Author: Kuldeepak Sharma, PhD, President/Pharmaceutical Consultant, Dr. Kuldeepak Sharma
Eventually, This Drug Will Be Banned
September 18, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-11-21T13:45:47.600